PRICE T ROWE ASSOCIATES INC /MD/
Position in LYEL — Lyell Immunopharma, Inc.
CIK 80255
BALTIMORE, MD
Position in LYEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$430,730
+$167,383 QoQ
Shares Held
30,657
+133.5% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. LYEL ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in LYEL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $430,730 | 30,657 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $263,347 | 13,128 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $404,079 | 13,128 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $213,198 | 13,128 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,705,561 | 306,059 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,485,613 | 6,478,836 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,422,879 | 6,910,749 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,146,141 | 7,352,277 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,414,934 | 7,872,369 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,011,193 | 6,731,477 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,879,432 | 6,638,883 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $9,828,708 | 6,686,197 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,952,278 | 8,161,094 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,362,917 | 3,967,338 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,754,629 | 3,675,686 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $38,897,428 | 5,306,607 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,735,273 | 5,327,496 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $27,744,306 | 5,493,922 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $39,793,592 | 5,141,291 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $54,157,196 | 3,659,270 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $40,600,000 | 2,500,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||